Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Mona Bafadhel, Associate Professor Respiratory Medicine and NIHR postdoctoral fellow, in the Nuffield Department of Clinical Medicine, was awarded the Royal College of Physicians Graham Bull Prize in the Clinical Sciences last week.

Professor Mona Bafadhel

The prize was established in 1988 in honour of Sir Graham Bull who was the first director of the Clinical Research Centre at Northwick Park and is awarded to young research workers who have made a major contribution to clinical science. On receiving the award, Professor Bafadhel commented:  

‘The evening was truly wonderful and it was a privilege to be presented this in the 500th year anniversary of the Royal College of Physicians. It is an honour to receive on behalf of my patients with chronic obstructive pulmonary disease, for women in the medical sciences and the Respiratory medical community.’

Professor Bafadhel has also been invited to deliver the Gaulstonian Lectureship, an annual lecture endowed in 1635 by Mrs Ellen Goulston in memory of her husband Dr Theodore Goulston FRCP. She will talk on the topic "Eosinophils in COPD: A breakthrough in patient management” in February next year.

 

Similar stories

Oxford University wins prestigious Queen’s Anniversary Prize

Her Majesty The Queen has approved the award of The Queen’s Anniversary Prizes to twenty-one higher and further education institutions, including Oxford University, in the most recent round of the independently reviewed scheme. This prestigious award is the highest national honour available to universities and FE colleges across the UK.

Jenner Institute named Covid Innovation Heroes

The team at the University of Oxford’s Jenner Institute has been celebrated for their global pandemic work by The Oxford Trust’s Covid Innovation Heroes Award­ 2021.

Study reveals ‘stop-eating’ response to DNA damage

A new study from the MRC Weatherall Institute of Molecular Medicine sheds light on the mechanism by which DNA damage suppresses appetite, a finding with implications for understanding the appetite lowering side-effects of chemotherapy.

Fiona Powrie appointed new Deputy Chair of Wellcome’s Board of Governors

Fiona Powrie, Director of the Kennedy Institute of Rheumatology at the University of Oxford has been selected as the next Deputy Chair of Wellcome’s Board of Governors.

World’s first cancer prevention trial to test diabetes drug in patients with high-risk genetic condition

Oxford researchers will lead a £2m national cancer prevention trial to assess the benefit a diabetes drug has in patients with Li Fraumeni Syndrome (LFS), a genetic condition that impacts 1 in 20,000 people worldwide and puts them at a 70-90% lifetime risk of cancer.